Synergistic interaction between PPAR ligands and salbutamol on human bronchial smooth muscle cell proliferation

British Journal of Pharmacology

Volumn 168, Issue 1, 2013, Pages 266-275

  Fogli, S ^a   Stefanelli, F ^a   Picchianti, L ^a   Del Re, M ^a   Mey, V ^a   Bardelli, C ^b   Danesi, R ^a   Breschi, M C ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

airway remodelling; airway smooth muscle cell; asthma; PPAR agonists; salbutamol; synergism

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; ROSIGLITAZONE; SALBUTAMOL;

APOPTOSIS; ARTICLE; BRONCHUS MUSCLE; CELL CYCLE; CELL NUCLEUS; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG POTENTIATION; ENZYME PHOSPHORYLATION; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NECROSIS; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AIRWAY REMODELING; ALBUTEROL; BRONCHI; CELL CYCLE; CELL DIVISION; CELL PROLIFERATION; CELLS, CULTURED; DRUG SYNERGISM; HUMANS; MYOCYTES, SMOOTH MUSCLE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; THIAZOLIDINEDIONES;

EID: 84872839020     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02180.x     Document Type: Article

References (36)

1. Adcock IM, Lane SJ, (2003). Corticosteroid-insensitive asthma: molecular mechanisms. J Endocrinol 178: 347-355.
2. Alexander SPH, Mathie A, Peters JA, (2011). Guide to receptors and channels (GRAC), 5th edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
3. Ammit AJ, Panettieri RA Jr, (2003). Airway smooth muscle cell hyperplasia: a therapeutic target in airway remodeling in asthma? Prog Cell Cycle Res 5: 49-57.
4. Barnes PJ, (2009). Corticosteroids. In:, Barnes PJ, Drazen JM, Rennard SI, Thompson NC, (eds). Asthma and COPD. Elsevier Science: San Diego, pp. 639-654.
5. Belvisi MG, Mitchell JA, (2009). Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease. Br J Pharmacol 158: 994-1003.
6. Bentley JK, Hershenson MB, (2008). Airway smooth muscle growth in asthma: proliferation, hypertrophy, and migration. Proc Am Thorac Soc 5: 89-96.
7. Billington CK, Ojo OO, Penn RB, Ito S, (2012). cAMP regulation of airway smooth muscle function. Pulm Pharmacol Ther [Epub ahead of print].
8. Bourdin A, Kleis S, Chakra M, Vachier I, Paganin F, Godard P, et al. (2012). Limited short-term steroid responsiveness is associated with thickening of bronchial basement membrane in severe asthma. Chest 141: 1504-1511.
9. Chou TC, Motzer RJ, Tong Y, Bosl GJ, (1994). Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design. J Natl Cancer Inst 86: 1517-1524.
10. De A, Blotta HM, Mamoni RL, Louzada P, Bertolo MB, Foss NT, et al. (2002). Effects of dexamethasone on lymphocyte proliferation and cytokine production in rheumatoid arthritis. J Rheumatol 29: 46-51.
11. Denning GM, Stoll LL, (2006). Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease? Pediatr Pulmonol 41: 23-34.
12. Düringer C, Grundström G, Gürcan E, Dainty IA, Lawson M, Korn SH, et al. (2009). Agonist-specific patterns of beta 2-adrenoceptor responses in human airway cells during prolonged exposure. Br J Pharmacol 158: 169-179.
13. Faisy C, Pinto FM, Blouquit-Laye S, Danel C, Naline E, Buenestado A, et al. (2010). beta2-Agonist modulates epithelial gene expression involved in the T- and B-cell chemotaxis and induces airway sensitization in human isolated bronchi. Pharmacol Res 61: 121-128.
14. Falcetti E, Hall SM, Phillips PG, Patel J, Morrell NW, Haworth SG, et al. (2010). Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 182: 1161-1170.
15. Firszt R, Kraft M, (2010). Pharmacotherapy of severe asthma. Curr Opin Pharmacol 10: 266-271.
16. Fogli S, Pellegrini S, Adinolfi B, Mariotti V, Melissari E, Betti L, et al. (2011). Rosiglitazone reverses salbutamol-induced β(2) -adrenoceptor tolerance in airway smooth muscle. Br J Pharmacol 162: 378-391.
17. Hassan M, Jo T, Risse PA, Tolloczko B, Lemière C, Olivenstein R, et al. (2010). Airway smooth muscle remodeling is a dynamic process in severe long-standing asthma. J Allergy Clin Immunol 125: 1037-1045.
18. Hirst SJ, Walker TR, Chilvers ER, (2000). Phenotypic diversity and molecular mechanisms of airway smooth muscle proliferation in asthma. Eur Respir J 16: 159-177.
19. Holownia A, Mroz RM, Noparlik J, Chyczewska E, Braszko JJ, (2008). Expression of CREB-binding protein and peroxisome proliferator-activated receptor gamma during formoterol or formoterol and corticosteroid therapy of chronic obstructive pulmonary disease. J Physiol Pharmacol 59 (Suppl. 6): 303-309.
20. Jarjour NN, Erzurum SC, Bleecker ER, Calhoun WJ, Castro M, Comhair SA, et al. (2012). Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. Am J Respir Crit Care Med 185: 356-362.
21. Kassel KM, Wyatt TA, Panettieri RA Jr, Toews ML, (2008). Inhibition of human airway smooth muscle cell proliferation by beta 2-adrenergic receptors and cAMP is PKA independent: evidence for EPAC involvement. Am J Physiol Lung Cell Mol Physiol 294: L131-L138.
22. Leesnitzer LM, Parks DJ, Bledsoe RK, Cobb JE, Collins JL, Consler TG, et al. (2002). Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41: 6640-6650.
23. Nie M, Corbett L, Knox AJ, Pang L, (2005). Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists. J Biol Chem 280: 2550-2561.
24. Niewoehner DE, (2010). Clinical practice. Outpatient management of severe COPD. N Engl J Med 362: 1407-1416.
25. Panettieri RA Jr, (2004). Effects of corticosteroids on structural cells in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 1: 231-234.
26. Pang L, Nie M, Corbett L, Knox AJ, (2003). Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors. J Immunol 170: 1043-1051.
27. Parfrey H, Farahi N, Porter L, Chilvers ER, (2010). Live and let die: is neutrophil apoptosis defective in severe asthma? Thorax 65: 665-667.
28. Roth M, Johnson PR, Rüdiger JJ, King GG, Ge Q, Burgess JK, et al. (2002). Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet 360: 1293-1299.
29. Spears M, Donnelly I, Jolly L, Brannigan M, Ito K, McSharry C, et al. (2009). Bronchodilatory effect of the PPAR-gamma agonist rosiglitazone in smokers with asthma. Clin Pharmacol Ther 86: 49-53.
30. Stewart AG, Tomlinson PR, Wilson JW, (1997). Beta 2-adrenoceptor agonist-mediated inhibition of human airway smooth muscle cell proliferation: importance of the duration of beta 2-adrenoceptor stimulation. Br J Pharmacol 121: 361-368.
31. Stewart AG, Harris T, Fernandes DJ, Schachte LC, Koutsoubos V, Guida E, et al. (1999). Beta2-adrenergic receptor agonists and cAMP arrest human cultured airway smooth muscle cells in the G(1) phase of the cell cycle: role of proteasome degradation of cyclin D1. Mol Pharmacol 56: 1079-1086.
32. Subbarayan V, Xu XC, Kim J, Yang P, Hoque A, Sabichi AL, et al. (2005). Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia. Neoplasia 7: 280-293.
33. Tomlinson PR, Wilson JW, Stewart AG, (1994). Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture. Br J Pharmacol 111: 641-647.
34. Wang W, Hayashi J, Serrero G, (2006). PC cell-derived growth factor confers resistance to dexamethasone and promotes tumorigenesis in human multiple myeloma. Clin Cancer Res 12: 49-56.
35. Ward JE, Gould H, Harris T, Bonacci JV, Stewart AG, (2004). PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms. Br J Pharmacol 141: 517-525.
36. Yan H, Deshpande DA, Misior AM, Miles MC, Saxena H, Riemer EC, et al. (2011). Anti-mitogenic effects of β-agonists and PGE2 on airway smooth muscle are PKA dependent. FASEB J 25: 389-397.